Featured Job
-
Job Removed or Not Found
Related Jobs
- Tris Pharma (Cranbury, NJ)
- …We have >150 US and International patents and market several branded ADHD products in the US We also license our products in the US and ex-US markets. We have a robust
- Monster (Anaheim, CA)
- …The Account Manager is responsible for managing customer relationships, estimating projects, and overseeing the successful execution of assigned projects. This role is
- UnitedHealth Group (San Antonio, TX)
- …Develop market business plans to motivate providers to engage in improving Stars measures to be 4 STARS or higher Provide analytical interpretation of Stars and HEDIS
- Tris Pharma (Monmouth Junction, NJ)
- …We have >150 US and International patents and market several branded ADHD products in the US We also license our products in the US and ex-US markets. We have a robust
- Tris Pharma (Houston, TX)
- …Adheres to all Standard Operating Procedures (SOPs), policies, processes and compliance guidelines and ensures knowledge of legal and regulatory requirements to
- Genmab (NJ)
- …Effectively support Genmab's Oncology portfolio in the US marketplace Responsible for meeting or exceeding assigned sales goals for the territory by effectively
- Tris Pharma (Monmouth Junction, NJ)
- …Cleans up and removes garbage from various manufacturing locations throughout the company, including cGMP areas Sweeps and cleans floor as required and maintains other
- Tris Pharma (Monmouth Junction, NJ)
- …We have >150 US and International patents and market several branded ADHD products in the US We also license our products in the US and ex-US markets. We have a robust
- Shimadzu Scientific Instruments (Charlotte, NC)
- …Bachelor's degree in a life science discipline; Chemistry strongly preferred Minimum of 3 years of successful sales experience with relevant analytical instruments,
- Tris Pharma (Monmouth Junction, NJ)
- …We have >150 US and International patents and market several branded ADHD products in the US We also license our products in the US and ex-US markets. We have a robust